Concepedia

Dirk Jäger

DJ

Statistics

Publications

80

Citations

8.7K

H-Index

41

Active since

1999

Affiliations

National Center for Tumor Diseases(Current)

Heidelberg University

University Hospital Heidelberg

German Cancer Research Center

Krankenhaus Nordwest

Dirk Jäger is an author at National Center for Tumor Diseases specializing in medicine, oncology, and pathology.

Top concepts

Publications per year

1999–2025

80

Publications

80

Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability–High/Mismatch Repair–Deficient Metastatic Colorectal Cancer: KEYNOTE-164

Dung T. Le, Tae Won Kim, Eric Van Cutsem et al. · Journal of Clinical Oncology · 2019 · 975 citations · Full text

Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein

Thomas Lindner, Anastasia Loktev, Annette Altmann et al. · Journal of Nuclear Medicine · 2018 · 874 citations · Full text

, , +22

A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts

Anastasia Loktev, Thomas Lindner, Walter Mier et al. · Journal of Nuclear Medicine · 2018 · 729 citations · Full text

, , +17

<sup>68</sup>Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers

Frederik L. Giesel, Clemens Kratochwil, Thomas Lindner et al. · Journal of Nuclear Medicine · 2018 · 674 citations · Full text

Development of Fibroblast Activation Protein–Targeted Radiotracers with Improved Tumor Retention

Anastasia Loktev, Thomas Lindner, Eva-Maria Burger et al. · Journal of Nuclear Medicine · 2019 · 499 citations · Full text

1–5 of 80